NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-219-2007-2-PCT-01 Dendrimer Conjugates Of Adenosine Receptor Agonists PCT PCT COMB PCT/US2008/067683 Expired
NIDDK E-219-2007-2-EP-03 Dendrimer Conjugates Of Agonists And Antagonists Of The GPCR Superfamily EP National Stage 08771603.1 Abandoned
NCI E-192-2007-0-PCT-02 Molecular Grading Methods PCT PCT PCT/US08/007699 Abandoned
CC E-195-2008-0-US-01 METHOD AND SYSTEM FOR PERFORMING BIOPSIES US 61/074,158 Abandoned
NIAID E-243-2006-2-MX-06 Nitroimidadzole Analogs With Improved TB Activity MX National Stage MX/a/2008/008195 Abandoned
NIAID E-145-2004-3-US-02 Monoclonal Antibodies Against Orthopoxviruses US National Stage 12/142,594 7914788 Issued PDF
NIAID E-243-2006-2-US-08 Nitroimidadzole Analogs With Improved TB Activity US National Stage 12/097,976 Abandoned
NIAID E-240-2007-0-AR-03 Development Of Antigenic Chimeric St. Louis Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses AR National Stage 2567-08-01 Abandoned
NINDS E-155-2006-0-JP-15 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties JP DIV 2014-202979 Issued
NINDS E-155-2006-0-EP-05 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties EA National Stage 08771137.0 Issued
NINDS E-155-2006-0-ES-10 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties ES National Stage 08771137.0 Issued
NINDS E-155-2006-0-GB-12 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties GB National Stage 08771137.0 Issued
NINDS E-155-2006-0-FR-11 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties FR National Stage 08771137.0 Issued
NINDS E-155-2006-0-DE-09 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties DE National Stage 08771137.0 Issued
NINDS E-155-2006-0-IT-13 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties IT National Stage 08771137.0 Issued
NINDS E-155-2006-0-JP-16 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties JP DIV 2014-202980 Issued
NINDS E-155-2006-0-JP-06 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties JP National Stage 2010-512418 Issued
NINDS E-155-2006-0-AU-03 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties AU National Stage 2008265898 Issued
NINDS E-155-2006-0-CA-04 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties CA National Stage 2698172 Issued
NINDS E-155-2006-0-PCT-02 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties PCT PCT PCT/US2008/067059 Expired
NCI E-157-1994-1-US-20 Methods and Compositions for Detecting Dihydropyrimidine Dehydrogenase Splicing Mutations US DIV 12/140,150 Abandoned
NCI E-064-2005-0-US-06 BIOMARKERS FOR TISSUE STATUS US National Stage 11/883,535 Abandoned
NCI E-200-1990-4-JP-23 GENERATION OF IMMUNE RESPONSES TO PROSTATE-SPECIFIC ANTIGEN (PSA) JP DIV 2008-156031 Abandoned
NIDDK E-235-2008-0-US-01 P2Y1 RECEPTOR ANTAGONISTS US 61/061,309 Abandoned
NIAID E-203-2008-0-US-01 MONITORING TCR-B TO DETERMINE HIV THERAPY AND DISEASE PROGRESSION US 61/131,954 Abandoned
NCI E-209-2008-0-US-01 USE OF MICRORNA-26 AS A PREDICTIVE MARKER FOR HEPATOCELLULAR CARCINOMA CLINICAL OUTCOME AND RESPONSE TO INTERFERON THERAPY US 61/131,800 Abandoned
NIAID E-240-2007-0-PCT-02 St. Louis Encephalitis Virus/Dengue Virus Type 4 Antigenic Chimeric Viruses PCT PCT PCT/US2008/066445 Expired
NIAID E-040-1999-0-US-16 Production of Attenuated Negative Stranded RNA Virus Vaccines From Cloned Nucleotide Sequences US DIV 12/136,765 Abandoned
NCI E-215-2007-0-CN-13 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells CN DIV 201310394618.6 Abandoned
NCI E-054-2008-0-CA-05 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith CA National Stage 2690410 Issued
NCI E-215-2007-0-EP-09 Methods for determining a hepatocellular carcinoma subtype EP DIV 12179595.9 Abandoned
NCI E-215-2007-0-FR-17 Methods for determining a hepatocellular carcinoma subtype FR EP 12179595.9 Abandoned
NCI E-215-2007-0-GB-18 Methods for determining a hepatocellular carcinoma subtype GB EP 12179595.9 Abandoned
NCI E-215-2007-0-GB-22 Methods for determining a hepatocellular carcinoma subtype GB EP 12179592.6 Abandoned
NCI E-215-2007-0-ES-20 Methods for determining a hepatocellular carcinoma subtype ES EP 12179592.6 Abandoned
NCI E-215-2007-0-DE-19 Methods for determining a hepatocellular carcinoma subtype DE EP 12179592.6 Abandoned
NCI E-215-2007-0-FR-21 Methods for determining a hepatocellular carcinoma subtype FR EP 12179592.6 Abandoned
NCI E-215-2007-0-EP-10 Methods for determining a hepatocellular carcinoma subtype EP DIV 12179592.6 Abandoned
NCI E-215-2007-0-JP-04 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells JP National Stage 2010-511218 Abandoned
NCI E-215-2007-0-GB-25 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE GB EP 08768266.2 Abandoned
NCI E-215-2007-0-IT-26 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE IT EP 08768266.2 Abandoned
NCI E-215-2007-0-EP-03 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE EP National Stage 08768266.2 Abandoned
NCI E-215-2007-0-FR-24 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE FR EP 08768266.2 Abandoned
NCI E-215-2007-0-ES-23 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE ES EP 08768266.2 Abandoned
NCI E-054-2008-0-US-03 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith US ORD 12/135,575 8765802 Abandoned PDF
NCI E-054-2008-0-GB-07 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith GB EP 08768252.2 Issued
NCI E-054-2008-0-DE-08 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith DE EP 08768252.2 Issued
NCI E-054-2008-0-FR-09 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith FR EP 08768252.2 Issued
NCI E-054-2008-0-EP-06 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith EP National Stage 08768252.2 Issued
NCI E-215-2007-0-AU-06 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells AU National Stage 2008262252 Abandoned